166 related articles for article (PubMed ID: 26065008)
1. Death Receptor 3 (TNFRSF25) Increases Mineral Apposition by Osteoblasts and Region Specific New Bone Formation in the Axial Skeleton of Male DBA/1 Mice.
Collins FL; Williams JO; Bloom AC; Stone MD; Choy E; Wang EC; Williams AS
J Immunol Res; 2015; 2015():901679. PubMed ID: 26065008
[TBL] [Abstract][Full Text] [Related]
2. CCL3 and MMP-9 are induced by TL1A during death receptor 3 (TNFRSF25)-dependent osteoclast function and systemic bone loss.
Collins FL; Williams JO; Bloom AC; Singh RK; Jordan L; Stone MD; McCabe LR; Wang ECY; Williams AS
Bone; 2017 Apr; 97():94-104. PubMed ID: 28062298
[TBL] [Abstract][Full Text] [Related]
3. TNF-like ligand 1A (TL1A) gene knockout leads to ameliorated collagen-induced arthritis in mice: implication of TL1A in humoral immune responses.
Wang X; Hu Y; Charpentier T; Lamarre A; Qi S; Wu J; Luo H
J Immunol; 2013 Dec; 191(11):5420-9. PubMed ID: 24140642
[TBL] [Abstract][Full Text] [Related]
4. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.
Meylan F; Richard AC; Siegel RM
Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439
[TBL] [Abstract][Full Text] [Related]
5. Death Receptor 3 Promotes Chemokine-Directed Leukocyte Recruitment in Acute Resolving Inflammation and Is Essential for Pathological Development of Mesothelial Fibrosis in Chronic Disease.
Perks WV; Singh RK; Jones GW; Twohig JP; Williams AS; Humphreys IR; Taylor PR; Jones SA; Wang ECY
Am J Pathol; 2016 Nov; 186(11):2813-2823. PubMed ID: 27664471
[TBL] [Abstract][Full Text] [Related]
6. Soluble TL1A is sufficient for activation of death receptor 3.
Bittner S; Knoll G; Füllsack S; Kurz M; Wajant H; Ehrenschwender M
FEBS J; 2016 Jan; 283(2):323-36. PubMed ID: 26509650
[TBL] [Abstract][Full Text] [Related]
7. The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis.
Bull MJ; Williams AS; Mecklenburgh Z; Calder CJ; Twohig JP; Elford C; Evans BA; Rowley TF; Slebioda TJ; Taraban VY; Al-Shamkhani A; Wang EC
J Exp Med; 2008 Oct; 205(11):2457-64. PubMed ID: 18824582
[TBL] [Abstract][Full Text] [Related]
8. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo.
Jacob N; Kumagai K; Abraham JP; Shimodaira Y; Ye Y; Luu J; Blackwood AY; Castanon SL; Stamps DT; Thomas LS; Gonsky R; Shih DQ; Michelsen KS; Targan SR
Sci Rep; 2020 Oct; 10(1):18189. PubMed ID: 33097818
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen-deficiency induces bone loss by modulating CD14
Collins FL; Stone MD; Turton J; McCabe LR; Wang ECY; Williams AS
BMC Musculoskelet Disord; 2019 Jul; 20(1):326. PubMed ID: 31299941
[TBL] [Abstract][Full Text] [Related]
10. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
Siakavellas SI; Bamias G
Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
[TBL] [Abstract][Full Text] [Related]
11. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.
Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F
J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692
[TBL] [Abstract][Full Text] [Related]
12. A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection.
Jia LG; Bamias G; Arseneau KO; Burkly LC; Wang EC; Gruszka D; Pizarro TT; Cominelli F
J Immunol; 2016 Jul; 197(1):377-86. PubMed ID: 27233964
[TBL] [Abstract][Full Text] [Related]
13. Local origins impart conserved bone type-related differences in human osteoblast behaviour.
Shah M; Gburcik V; Reilly P; Sankey RA; Emery RJ; Clarkin CE; Pitsillides AA
Eur Cell Mater; 2015 Mar; 29():155-75; discussion 175-6. PubMed ID: 25738584
[TBL] [Abstract][Full Text] [Related]
14. The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases.
Siakavellas SI; Sfikakis PP; Bamias G
Semin Arthritis Rheum; 2015 Aug; 45(1):1-8. PubMed ID: 25887448
[TBL] [Abstract][Full Text] [Related]
15. Death receptor 3 mediates TNFSF15- and TNFα-induced endothelial cell apoptosis.
Xu LX; Grimaldo S; Qi JW; Yang GL; Qin TT; Xiao HY; Xiang R; Xiao Z; Li LY; Zhang ZS
Int J Biochem Cell Biol; 2014 Oct; 55():109-18. PubMed ID: 25161149
[TBL] [Abstract][Full Text] [Related]
16. Death receptor 3 signaling enhances proliferation of human regulatory T cells.
Bittner S; Knoll G; Ehrenschwender M
FEBS Lett; 2017 Apr; 591(8):1187-1195. PubMed ID: 28337757
[TBL] [Abstract][Full Text] [Related]
17. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
Valatas V; Kolios G; Bamias G
Front Immunol; 2019; 10():583. PubMed ID: 30972074
[TBL] [Abstract][Full Text] [Related]
18. Progranulin-derived Atsttrin directly binds to TNFRSF25 (DR3) and inhibits TNF-like ligand 1A (TL1A) activity.
Liu C; Li XX; Gao W; Liu W; Liu DS
PLoS One; 2014; 9(3):e92743. PubMed ID: 24651300
[TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
[TBL] [Abstract][Full Text] [Related]
20. The Role of the TL1A/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma.
Machida K; Aw M; Salter BMA; Ju X; Mukherjee M; Gauvreau GM; O'Byrne PM; Nair P; Sehmi R
Am J Respir Crit Care Med; 2020 Oct; 202(8):1105-1114. PubMed ID: 32584596
[No Abstract] [Full Text] [Related]
[Next] [New Search]
